Company / Revenue per Share
Alaunos Therapeutics, Inc. Revenue per Share History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.01
FY2025
5-year range
$0.00 / $0.18
FY2021-FY2025
Trend
+100.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 9 years, ranging from $0.00 in FY2021 to $0.18 in FY2023.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of +50.7%.
Declined from $0.18 to $0.01 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +50.2%
- 5-Year CAGR
- +50.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share increased 100.0% year-over-year.
- Peak revenue per share was recorded in FY2023.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +100.0% |
| FY2024 | $0.00 | -98.3% |
| FY2023 | $0.18 | +9800.2% |
| FY2022 | $0.00 | - |
| FY2021 | $0.00 | -100.0% |
| FY2020 | $0.00 | -99.2% |
| FY2019 | $0.10 | -11.4% |
| FY2018 | $0.11 | - |
| FY2013 | - | - |
| FY2012 | $0.01 | -30.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026